BOSTON — NanoMosaic L.L.C. announced today it is commercializing technology for high-throughput, high-sensitivity analyte detection initially developed at Harvard University, through an exclusive license agreement with Harvard Office of Technology Development. NanoMosaic’s screening tools may aid in a number of biomedical fields including the early detection of disease, prognostic monitoring, biomarker discovery, and infectious disease […]

LEIDEN – BIOKÉ, a business unit of Cell Signaling Technology Europe, announced it has signed a distribution agreement with abc biopply, an innovative and dynamic biotech company, to distribute abc biopply’s 3D CoSeedis™ cell culture technology in the Netherlands, Belgium and Luxembourg (Benelux), effective immediately. “We cannot wait to bring the novel 3D CoSeedis™ cell […]

ROLLING MEADOWS, Ill. — Berg Engineering & Sales Company, Inc. provides equipment and services for industrial testing. Berg announces the immediate availability of the S1 Titan, CTX and Tracer, the next generation of Bruker X-ray fluorescence (XRF) analyzers used in non-destructive elemental analysis. XRF analyzers are used in many industries including automotive, mining, aerospace, metal recycling, […]

StarDrop™ and Augmented Chemistry™ prove a powerful combination in AI-guided design and validation of novel antimalarial drug candidates In silico designed compound demonstrates potency against pfATP4 protein target in malaria parasite CAMBRIDGE, UK  – Optibrium™, leading providers of software and services for drug discovery, and Intellegens™, a spin-out from the University of Cambridge with a […]

908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced an expansion of their joint innovation partnership with Transcenta, a fully integrated global biotherapeutics company. The company’s world-class technology center (“Center”) for biotherapeutic process and product development and manufacturing subsidiary, HJB, is located in Hangzhou, China. 908 Devices and Transcenta’s HJB […]

Micro-RNA compound found suitable for further development following favorable pharmacokinetic and pharmacodynamic study results Cambridge, UK, and Budapest, Hungary  Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, and Pharmahungary Group, a preclinical and clinical R&D […]

READY-TO-GO PROCESSING SOLUTION FOR COVID-19 HIGH COMPLEXITY TESTING LABS   Zymo Research and Tecan partner to launch a ready-to-go processing solution that streamlines viral DNA/RNA extraction from nasopharyngeal and oropharyngeal swabs, saliva, sputum, plasma, and serum. IRVINE, Calif.  —Zymo Research announced today a partnership with Tecan to launch a ready-to-go processing solution to streamline viral DNA/RNA […]

Lausanne, Switzerland, and Boston, United States: SOPHiA GENETICS, leader in Data-Driven Medicine, today announced that it is entering the fight against the COVID-19 coronavirus by extending its partnership with Paragon Genomics, who developed a next-generation sequencing (NGS) assay and leveraging the SOPHiA Platform analytical capabilities, as well as delivering the benefits of this solution to […]

SOUTH SAN FRANCISCO, Calif.– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Vanderbilt University Medical Center (VUMC) to supply synthetic genes and antibodies for the development of therapies for COVID-19. In addition, Twist Biopharma, a division […]